European Investor
01 Jul 2026, 15:07
Salesforce (CRM) Stock Rises After Wave of Analyst Upgrades and New Coverage
Salesforce (NYSE: CRM) shares gained approximately 5.2% on Wednesday after receiving a series of positive analyst actions, including multiple upgrades, new coverage initiations, and bullish recommendations that reinforced confidence in the software company's AI-driven growth strategy.
The broad-based analyst support comes as Wall Street grows increasingly optimistic about Salesforce's ability to monetize artificial intelligence while maintaining strong profitability and cash flow.
# Multiple Firms Turn More Bullish
Guggenheim upgraded Salesforce from Neutral to Buy and assigned a $228 price target.
Citigroup also upgraded the stock from Market Outperform to Buy, reflecting increased confidence in the company's long-term growth outlook.
Jefferies upgraded Salesforce to Buy, while UBS initiated coverage with an Overweight rating and Wedbush launched coverage with an Outperform rating.
Susquehanna initiated coverage with a Neutral rating, while Wolfe Research was the lone cautious voice, downgrading the stock from Outperform to Peer Perform.
# AI Strategy Continues to Attract Investors
Analysts remain optimistic that Salesforce's expanding portfolio of AI-powered products, including its Agentforce platform, will drive higher customer spending and improve productivity across its enterprise software ecosystem.
The company also continues to benefit from disciplined cost management, improving margins, and resilient demand for its customer relationship management platform.
# Why CRM Stock Is Rising Today
Several analyst actions supported the stock:
* Guggenheim upgraded the stock to Buy with a $228 price target.
* Citigroup upgraded Salesforce to Buy.
* Jefferies upgraded the shares to Buy.
* UBS initiated coverage with an Overweight rating.
* Wedbush initiated coverage with an Outperform rating.
* Investors largely overlooked Wolfe Research's downgrade as positive analyst sentiment dominated.
The wave of favorable analyst actions reinforced Wall Street's confidence in Salesforce's long-term growth prospects, helping lift the stock more than 5% during Wednesday's session.
Salesforce (NYSE: CRM) shares gained approximately 5.2% on Wednesday after receiving a series of positive analyst actions, including multiple upgrades, new coverage initiations, and bullish recommendations that reinforced confidence in the software company's AI-driven growth strategy.
The broad-based analyst support comes as Wall Street grows increasingly optimistic about Salesforce's ability to monetize artificial intelligence while maintaining strong profitability and cash flow.
# Multiple Firms Turn More Bullish
Guggenheim upgraded Salesforce from Neutral to Buy and assigned a $228 price target.
Citigroup also upgraded the stock from Market Outperform to Buy, reflecting increased confidence in the company's long-term growth outlook.
Jefferies upgraded Salesforce to Buy, while UBS initiated coverage with an Overweight rating and Wedbush launched coverage with an Outperform rating.
Susquehanna initiated coverage with a Neutral rating, while Wolfe Research was the lone cautious voice, downgrading the stock from Outperform to Peer Perform.
# AI Strategy Continues to Attract Investors
Analysts remain optimistic that Salesforce's expanding portfolio of AI-powered products, including its Agentforce platform, will drive higher customer spending and improve productivity across its enterprise software ecosystem.
The company also continues to benefit from disciplined cost management, improving margins, and resilient demand for its customer relationship management platform.
# Why CRM Stock Is Rising Today
Several analyst actions supported the stock:
* Guggenheim upgraded the stock to Buy with a $228 price target.
* Citigroup upgraded Salesforce to Buy.
* Jefferies upgraded the shares to Buy.
* UBS initiated coverage with an Overweight rating.
* Wedbush initiated coverage with an Outperform rating.
* Investors largely overlooked Wolfe Research's downgrade as positive analyst sentiment dominated.
The wave of favorable analyst actions reinforced Wall Street's confidence in Salesforce's long-term growth prospects, helping lift the stock more than 5% during Wednesday's session.